NO20050132L - Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler - Google Patents

Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler

Info

Publication number
NO20050132L
NO20050132L NO20050132A NO20050132A NO20050132L NO 20050132 L NO20050132 L NO 20050132L NO 20050132 A NO20050132 A NO 20050132A NO 20050132 A NO20050132 A NO 20050132A NO 20050132 L NO20050132 L NO 20050132L
Authority
NO
Norway
Prior art keywords
blend
outer membrane
vaccine composition
membrane vesicles
meningococcal
Prior art date
Application number
NO20050132A
Other languages
English (en)
Norwegian (no)
Other versions
NO20050132D0 (no
Inventor
Pierre Michel Desmons
Jan Poolman
Ramon Faustino Barbera Morales
Francisco Jesus Doming Alvarez
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20050132D0 publication Critical patent/NO20050132D0/no
Publication of NO20050132L publication Critical patent/NO20050132L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20050132A 2002-06-13 2005-01-11 Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler NO20050132L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213622.4A GB0213622D0 (en) 2002-06-13 2002-06-13 Vaccine Corporation
PCT/EP2003/006094 WO2003105890A2 (en) 2002-06-13 2003-06-10 Vaccine composition

Publications (2)

Publication Number Publication Date
NO20050132D0 NO20050132D0 (no) 2005-01-11
NO20050132L true NO20050132L (no) 2005-02-11

Family

ID=9938532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050132A NO20050132L (no) 2002-06-13 2005-01-11 Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler

Country Status (20)

Country Link
US (1) US20060110412A1 (xx)
EP (1) EP1565211A2 (xx)
JP (1) JP2005531614A (xx)
KR (1) KR20050049431A (xx)
CN (1) CN100387298C (xx)
AR (1) AR040204A1 (xx)
AU (1) AU2003236734A1 (xx)
BR (1) BR0311777A (xx)
CA (1) CA2488782A1 (xx)
CL (1) CL2003001192A1 (xx)
CU (1) CU23552A1 (xx)
GB (1) GB0213622D0 (xx)
MX (1) MXPA04012568A (xx)
NO (1) NO20050132L (xx)
NZ (1) NZ560766A (xx)
PE (1) PE20040562A1 (xx)
RU (1) RU2005100509A (xx)
UY (1) UY27843A1 (xx)
WO (1) WO2003105890A2 (xx)
ZA (1) ZA200409547B (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03000822A (es) 2000-07-27 2004-11-01 Childrens Hosp & Res Ct Oak Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis.
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
NZ555937A (en) 2005-01-27 2009-05-31 Childrens Hosp & Res Ct Oak GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
CA2808919C (en) * 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
AU2007293673B2 (en) 2006-09-07 2013-06-27 Glaxosmithkline Biologicals S.A. Vaccine
JP5701058B2 (ja) 2007-10-19 2015-04-15 ノバルティス アーゲー 髄膜炎菌ワクチン処方物
WO2009062132A2 (en) 2007-11-09 2009-05-14 California Institute Of Technology Immunomodulating compounds and related compositions and methods
EP2235531B1 (en) * 2008-02-01 2015-01-14 Sanofi Pasteur Limited Assay for diagnosing streptococcus pneumoniae
US8466167B2 (en) 2008-03-03 2013-06-18 Irm Llc Compounds and compositions as TLR activity modulators
AU2009329193A1 (en) 2008-12-17 2011-07-14 Novartis Ag Meningococcal vaccines including hemoglobin receptor
TR201802380T4 (tr) 2009-06-10 2018-03-21 Glaxosmithkline Biologicals Sa Benzonaftiridin içeren aşılar.
JP2013503148A (ja) 2009-08-27 2013-01-31 ノバルティス アーゲー アルミニウム、オリゴヌクレオチドおよびポリカチオンを含むアジュバント
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
US8691522B2 (en) * 2009-10-08 2014-04-08 Aeon Medix Inc. Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
JP5814933B2 (ja) 2009-12-15 2015-11-17 ノバルティス アーゲー 免疫増強化合物の均質な懸濁物およびその使用
KR20120107121A (ko) * 2009-12-22 2012-09-28 사노피 파스퇴르 리미티드 면역원성 조성물
CN102802662A (zh) 2010-03-18 2012-11-28 诺华有限公司 用于脑膜炎球菌血清组b的含佐剂疫苗
EP2549990A1 (en) 2010-03-23 2013-01-30 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
US20110251156A1 (en) 2010-04-07 2011-10-13 Yue Shen Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
CA2810971C (en) * 2010-09-10 2020-11-03 Novartis Ag Developments in meningococcal outer membrane vesicles
EP2707009A1 (en) 2011-05-12 2014-03-19 Novartis AG Antipyretics to enhance tolerability of vesicle-based vaccines
JP6273200B2 (ja) 2011-07-12 2018-01-31 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド 脂質含有ｐｓａ組成物、その単離の方法および使用の方法
EP3299467B1 (en) 2012-02-02 2021-08-11 GlaxoSmithKline Biologicals SA Promoters for increased protein expression in meningococcus
EP2823312B1 (en) 2012-03-08 2019-08-07 GlaxoSmithKline Biologicals SA In vitro potency assay for protein-based meningococcal vaccines
NZ630133A (en) 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
RU2015106930A (ru) 2012-09-06 2016-10-20 Новартис Аг Комбинированные вакцины с менингококком серогруппы в и к/д/с
WO2016201342A1 (en) 2015-06-10 2016-12-15 California Institute Of Technology Sepsis treatment and related compositions methods and systems
EP3337321A4 (en) 2015-08-19 2019-07-17 President and Fellows of Harvard College LIPIDED PSA COMPOSITIONS AND METHOD
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use
JP7104027B2 (ja) 2016-09-02 2022-07-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 淋菌に対するワクチン
EP4232158A1 (en) * 2020-10-23 2023-08-30 Omvax, Inc. Compositions and methods for vaccination against neisseria gonorrhoeae
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2297072A1 (en) * 1997-07-17 1999-01-28 North American Vaccine, Inc. Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
MXPA03000822A (es) * 2000-07-27 2004-11-01 Childrens Hosp & Res Ct Oak Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis.

Also Published As

Publication number Publication date
GB0213622D0 (en) 2002-07-24
RU2005100509A (ru) 2006-06-10
UY27843A1 (es) 2003-12-31
PE20040562A1 (es) 2004-10-19
CU23552A1 (es) 2010-07-20
MXPA04012568A (es) 2005-09-21
CA2488782A1 (en) 2003-12-24
CL2003001192A1 (es) 2005-01-07
WO2003105890A3 (en) 2004-03-25
WO2003105890A2 (en) 2003-12-24
NZ560766A (en) 2009-09-25
US20060110412A1 (en) 2006-05-25
AR040204A1 (es) 2005-03-16
AU2003236734A1 (en) 2003-12-31
CN1668329A (zh) 2005-09-14
EP1565211A2 (en) 2005-08-24
KR20050049431A (ko) 2005-05-25
ZA200409547B (en) 2006-07-26
CN100387298C (zh) 2008-05-14
JP2005531614A (ja) 2005-10-20
NO20050132D0 (no) 2005-01-11
BR0311777A (pt) 2005-03-29

Similar Documents

Publication Publication Date Title
NO20050132L (no) Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler
RU2378009C2 (ru) Иммунизация против менингококков серогруппы y с помощью белков
MX2010012999A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
WO2004014417A3 (en) Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis
MX349481B (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
MX2010004549A (es) Composiciones y métodos bacteriostáticos o bactericidas.
MX2009004223A (es) Protocolo de inmunizacion contra los 4 serotipos del dengue.
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
HU229368B1 (en) Novel vaccine composition
NZ593674A (en) Meningococcal vaccines including hemoglobin receptor
MX2009006760A (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedades meningococicas.
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
EA200870393A1 (ru) Новые композиции для нарушений волос и способ получения композиций
BR0015961A (pt) Antìgeno de neisseria de 85kda
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20065835L (no) Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander
NO20054662L (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
NO20063017L (no) Protein NMB0928 og anvendelse derav i farmasoytiske formuleringer
DE602004019971D1 (de) Kombinationsvakzine für geflügel
Norheim et al. Prevention of serogroup A, C and W135 meningococcal disease in Africa with outer membrane vesicle vaccines
IS5075A (is) 1-fenýlalkýl-1,2,3,6-tetrahýdrópýrídín til meðhöndlunar Alzheimer-sjúkdómsins
ATE495757T1 (de) Attenuierte bakterielle lebendvakzine
NO20072090L (no) Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav II

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application